The Cyberspace Administration of China released for public consultation its long-awaited template for the cross-border data transfer agreement on June 30, 2022, under the draft Provisions on the Prescribed Agreement on...more
Leading up to the June 21 effective date, US Customs and Border Protection issued operational guidance and a strategy document to assist importers with Uyghur Forced Labor Prevention Act compliance and to define its...more
6/23/2022
/ China ,
Customs and Border Protection ,
Department of Labor (DOL) ,
Forced Labor ,
Human Rights ,
Importers ,
Imports ,
Supply Chain ,
Trade Restrictions ,
US Trade Policies ,
Uyghur Forced Labor Prevention Act (UFLPA)
China’s legal framework around data protection and security is governed broadly by three key pieces of legislation: the Cybersecurity Law, which came into effect in 2017, and the Data Security Law (DSL) and the Personal...more
China has passed new regulations on imported food, affecting overseas food manufacturers, processors, and storage facilities. These regulations include requirements regarding registration, labelling and packaging, as well as...more
Multinational pharmaceutical companies, by nature of their business, handle a great deal of data, often transferred across borders, whether based on research, clinical trial data, and employee personal data....more
10/11/2021
/ China ,
Clinical Trials ,
Cybersecurity ,
Data Controller ,
Data Processors ,
Data Protection ,
Data Security ,
Genetic Materials ,
International Data Transfers ,
Life Sciences ,
Multinationals ,
Personal Information Protection Law (PIPL)
China’s long-awaited Personal Information Protection Law (PIPL), after two rounds of draft versions, was finally passed by the Standing Committee of the National People's Congress on August 20, 2021, with the law effective...more
8/24/2021
/ China ,
Corporate Counsel ,
Cybersecurity ,
Data Controller ,
Data Processors ,
Data Protection ,
General Data Protection Regulation (GDPR) ,
International Data Transfers ,
Personal Data ,
Personal Information ,
Popular ,
Regulatory Reform
China’s new Data Security Law includes more expansive and restrictive requirements on data localization, mandatory security level certification, and severe penalties on unauthorized foreign transfer of data....more
China recently amended its primary regulation governing medical devices, the Regulation on Supervision and Administration of Medical Devices (2021 RSAMD), which will replace its previous 2014 version and become effective on...more
China’s Ministry of Commerce (MOFCOM) published the Rules on Counteracting Unjustified Extraterritorial Application of Foreign Legislation and Other Measures (the Blocking Statutes) on January 9. The rules, which consist of...more
Long-awaited legislation in China—the Personal Information Protection Law of the People’s Republic of China—was released for public consultation on October 21. Once passed, the law will be the first designated personal...more
The Chinese government has been actively promoting internet-based medicine in mainland China since 2014. On July 17, 2018, the National Health Committee (NHC) and the State Administration of Traditional Chinese Medicine...more
During the coronavirus (COVID-19) pandemic, we have seen a dramatic shift from in-person visits to telehealth services around the globe, unveiling what may be the new normal for providing healthcare services....more
8/14/2020
/ China ,
Coronavirus/COVID-19 ,
Germany ,
Health Care Providers ,
Infrastructure ,
Patient Access ,
Singapore ,
Telehealth ,
Telemedicine ,
United Arab Emirates (UAE) ,
United States
During the coronavirus (COVID-19) pandemic, we have seen a dramatic shift from in-person visits to telehealth services around the globe, unveiling what may be the new normal for providing healthcare services....more
In this LawFlash, we outline the expense fraud scheme reported in a 2019 case involving the crime of illegal sale of “fapiaos,” examine some typical expense fraud schemes in China, and provide our practical takeaways with...more
The new measure, which will come into effect on June 1, 2020, will potentially affect operators of critical information infrastructures as well as their domestic and overseas suppliers. Affected companies should now take...more
The growth of automobile production and sales in China, particularly in the realm of alternative fuel vehicles (New Energy Vehicles or NEVs), has been nothing short of explosive, experiencing a nearly 1,000-fold increase...more
EU – REGULATORY -
Brexit, Notified Bodies, and Medical Devices -
The House of Commons Library published a briefing paper on June 12 on the UK’s product standards and safety marking compliance in light of Brexit. In the...more
8/20/2019
/ Anti-Kickback Statute ,
Asia ,
China ,
Competition ,
Data Privacy ,
Drug Pricing ,
EU ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Patents ,
Pharmaceutical Industry ,
UK Brexit
Chinese customs authorities have stepped up transfer pricing enforcement in recent years. Here are some of the steps multinational companies should take to address the enforcement risks....more
In an effort to drive down medical costs, the PRC Ministry of Finance has announced it will audit 77 randomly selected drug makers in China in order to examine the companies’ costs and profits and determine the reasonableness...more
The Administration for Market Regulation of Jing’an District in Shanghai (AMR) on May 7 announced an administrative penalty decision against the Shanghai branch of a multinational pharmaceutical company (the Branch) for...more
China has long been criticized for having enacted various regulations allowing discriminatory technology licensing practices against foreign technology owners. These regulations restrict the ability of foreign technology...more
The Amended Individual Income Tax Law has implications for both Chinese nationals and expatriates working in the People’s Republic of China. Notably, tax residency, and its accompanying individual income tax liability, will...more
Under new rules effective January 1, 2019, Chinese tax authorities will now collect social insurance fees on the actual income paid to employees based on the monthly reporting of income for individual income tax filings....more
Expanding on recent reforms allowing innovative pharmaceutical drugs to be approved on the basis of overseas clinical trial data, China’s National Medical Products Administration (NMPA) has created special channels for the...more
Under recent Chinese banking regulations, which include the increased regulation of asset and wealth management products, licensed commercial banks must have prior approval and licensing to engage in the marketing and sale of...more